Hydralazine Hydrochloride
- Product NDC
- 0517-0901
- 11-digit product format
- 005170901
- Labeler code
- 0517
- Product ID
- 0517-0901_5aca9ccd-3ac3-48b6-9372-34ee0eb4b7f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- American Regent, Inc.
- Application
- ANDA040136
- Marketing category
- ANDA
- Marketing start
- 1997-06-30
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydralazine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYDRALAZINE HYDROCHLORIDE | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FD171B778Y |
| Rxcui | 966571 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0517-0901-25 | Hydralazine Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 8 |
| 0517-0901-25 | Hydralazine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 1 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYDRALAZINE HYDROCHLORIDE | ACTIVE INGREDIENT | FD171B778Y | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| HYDRALAZINE | ACTIVE MOIETY | 26NAK24LS8 | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0517-0901 | HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20190507_17210abc-58f6-442e-8ff2-7971333c82f6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0517-0901-25 | 00517090125 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) / 1 mL in 1 VIAL, SINGLE-DOSE | 1997-06-30 | 0000-00-00 | No | No | Current |